Sunshine Biopharma
Sunshine Biopharma

Sunshine Biopharma

Pharmaceuticals
WebsiteInvestor RelationsSEC
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

$3M

Market Cap • 10/7/2026

2006

(20 years)

Founded

2007

(19 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,1

P/S

0,1

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

6,4

EPS

—

Market Cap

Market Cap

3M

EV

-10M

EV/Revenue

-0,3

EV/EBITDA

1,8

EV/EBIT

1,7

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-282,7%

Total Yield

-282,7%

Payout

0%

Retained Earnings

-77,8M

Profitability

Gross Margin

30,3%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0,1%

Capex/D&A

5,5%

Capex/OCF

-0,4%

SBC/OCF

—

% PPE

3,3%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

203,1%

CAGR Op. Income 5Y

23,2%

CAGR Net Income 5Y

-11,7%

CAGR OCF 5Y

29,7%

Leverage

N.D./EBITDA

2,4

Debt/Equity

0%

Current Ratio

3,3

Quick Ratio

3,2

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium